Publications
pharmacokinetics of curcumin tagged cilostazol nanodispersion for the management of diabetic nephropathy in wister rat model. In Silico Pharmacol. 2024 Sep 2;12(2):81. (Impact Factor 1.2)
2. Monika, Singh RP. Emerging trends and persistent challenges in nanomedicine for rheumatoid arthritis therapy. Curr Rheumatol Rev. 2024 Jul 26. (Impact Factor 1.2) [Corresponding Author]
3. Singh RP, Sonali. Current trends and challenges in targeting tumor mitochondrial glycolysis and oxidative phosphorylation pathways for cancer therapy. Curr Protein Pept Sci. 2024 Jul 3. doi: 10.2174/0113892037307636240612112408. (Impact Factor 1.9) [Corresponding Author]
4. Tanushree, Sharma A, Monika, Singh RP, Jhawat V. Human immunodeficiency virus infection challenges: Current therapeutic limitations and strategies for improved management through long-acting injectable formulation. Rev Med Virol. 2024 Jul;34(4):e2563. (Impact Factor 9)
5. Yadav B, Chauhan M, Sonali, Dinkar R, Shekhar S, Monika, Singh RP. In silico modeling, development, characterization, in-vitro cytotoxicity, pharmacokinetic, and toxicological studies of folate-receptor targeted micelles containing cisplatin and upconversion nanoparticles for lung cancer therapy. Materials Today Communications. 2024, 39: 109007. (Impact Factor 3.7) [Corresponding Author]
6. Chauhan M, Sonali, Shekhar S, Yadav B, Garg V, Dutt R, Mehata AK, Goswami P, Koch B, Muthu MS, Singh RP. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanopar